The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
FSP1: a key regulator of ferroptosis
Open accessAbstract
Ferroptosis suppressor protein 1 (FSP1) is one of the main regulatory molecules of ferroptosis. FSP1 functions through the FSP1-coenzyme Q10 (CoQ10)-NAD(P)H axis and the vitamin K redox cycle. FSP1 is regulated by upstream factors, including transcription factors and noncoding RNA (ncRNA), and is subject to epigenetic modifications, which affect the progress of FSP1-related diseases. FSP1 is closely associated with the poor prognosis of malignant tumors and plays an important role in disease treatment. This review aims to provide a comprehensive understanding of the role of FSP1 in ferroptosis regulation by summarizing regulatory pathways, possible mechanisms involving FSP1, and the relationship between FSP1 and disease prognosis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Feng, Z., Li, K., Qin, K., Liang, J., Shi, M., Ma, Y., Zhao, S., Liang, H., Han, D., Shen, B., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01338-9 · Cited by 72
RetractedInactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Bersuker, K., Hendricks, J. M., Li, Z., Magtanong, L., Ford, B., Tang, P. H., Roberts, M. A., Tong, B., Maimone, T. J., Zoncu, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1705-2 · Cited by 3,703
FSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
The Noncoding RNA Revolution—Trashing Old Rules to Forge New Ones
Cech, T. R., & Steitz, J. A. (2014) · Cell · doi:10.1016/j.cell.2014.03.008 · Cited by 2,524
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
Yang, W. S., Kim, K. J., Gaschler, M. M., Patel, M., Shchepinov, M. S., & Stockwell, B. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603244113 · Cited by 2,329
Targeting Ferroptosis as a Vulnerability in Cancer
Lei, G., Zhuang, L., & Gan, B. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00459-0 · Cited by 2,252
The Metabolic Underpinnings of Ferroptosis
Zheng, J., & Conrad, M. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.011 · Cited by 1,329
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
Li, T., Hu, P.-S., Zuo, Z., Lin, J.-F., Li, X., Wu, Q.-N., Chen, Z.-H., Zeng, Z.-L., Wang, F., Zheng, J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1038-7 · Cited by 799
A non-canonical vitamin K cycle is a potent ferroptosis suppressor
Mishima, E., Ito, J., Wu, Z., Nakamura, T., Wahida, A., Doll, S., Tonnus, W., Nepachalovich, P., Eggenhofer, E., Aldrovandi, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05022-3 · Cited by 713
mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation
Zhang, Y., Swanda, R. V., Nie, L., Liu, X., Wang, C., Lee, H., Lei, G., Mao, C., Koppula, P., Cheng, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21841-w · Cited by 698
Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease
Bao, W.-D., Pang, P., Zhou, X.-T., Hu, F., Xiong, W., Chen, K., Wang, J., Wang, F., Xie, D., Hu, Y.-Z., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00685-9 · Cited by 671
Yan, H., & Bu, P. (2021) · Essays in Biochemistry · doi:10.1042/ebc20200032 · Cited by 667
The KEAP1–NRF2 System in Cancer
Taguchi, K., & Yamamoto, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00085 · Cited by 527
Koppula, P., Lei, G., Zhang, Y., Yan, Y., Mao, C., Kondiparthi, L., Shi, J., Liu, X., Horbath, A., Das, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29905-1 · Cited by 464
Self-citationACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury
Wang, Y., Zhang, M., Bi, R., Su, Y., Quan, F., Lin, Y., Yue, C., Cui, X., Zhao, Q., Liu, S., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102262 · Cited by 431
Self-citationRedox homeostasis maintained by GPX4 facilitates STING activation
Jia, M., Qin, D., Zhao, C., Chai, L., Yu, Z., Wang, W., Tong, L., Lv, L., Wang, Y., Rehwinkel, J., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0699-0 · Cited by 425
ALIX- and ESCRT-III–dependent sorting of tetraspanins to exosomes
Larios, J., Mercier, V., Roux, A., & Gruenberg, J. (2020) · Journal of Cell Biology · doi:10.1083/jcb.201904113 · Cited by 422
Ye, Y., Chen, A., Li, L., Liang, Q., Wang, S., Dong, Q., Fu, M., Lan, Z., Li, Y., Liu, X., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.07.034 · Cited by 360
Chen, X., Gong, W., Shao, X., Shi, T., Zhang, L., Dong, J., Shi, Y., Shen, S., Qin, J., Jiang, Q., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221091 · Cited by 359
Wang, S., Li, W., Zhang, P., Wang, Z., Ma, X., Liu, C., Vasilev, K., Zhang, L., Zhou, X., Liu, L., et al. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.01.004 · Cited by 295
Self-citationFerroptosis in the tumor microenvironment: perspectives for immunotherapy
Xu, H., Ye, D., Ren, M., Zhang, H., & Bi, F. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.06.014 · Cited by 294
Structures, Functions, and Dynamics of ESCRT-III/Vps4 Membrane Remodeling and Fission Complexes
McCullough, J., Frost, A., & Sundquist, W. I. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100616-060600 · Cited by 276
ESCRT-III–dependent membrane repair blocks ferroptosis
Dai, E., Meng, L., Kang, R., Wang, X., & Tang, D. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.110 · Cited by 273
Tonnus, W., Meyer, C., Steinebach, C., Belavgeni, A., von Mässenhausen, A., Gonzalez, N. Z., Maremonti, F., Gembardt, F., Himmerkus, N., Latk, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24712-6 · Cited by 264
Self-citationStem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11
Wang, X., Chen, Y., Wang, X., Tian, H., Wang, Y., Jin, J., Shan, Z., Liu, Y., Cai, Z., Tong, X., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0567 · Cited by 264
Mladěnka, P., Macáková, K., Kujovská Krčmová, L., Javorská, L., Mrštná, K., Carazo, A., Protti, M., Remião, F., Nováková, L., & collaborators, T. O. R. A. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab061 · Cited by 262
Li, K., Lin, C., Li, M., Xu, K., He, Y., Mao, Y., Lu, L., Geng, W., Li, X., Luo, Z., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c08664 · Cited by 262
Song, Z., Jia, G., Ma, P., & Cang, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119399 · Cited by 260
Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain
Yoo, S.-E., Chen, L., Na, R., Liu, Y., Rios, C., Van Remmen, H., Richardson, A., & Ran, Q. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.043 · Cited by 248
Wohlhieter, C. A., Richards, A. L., Uddin, F., Hulton, C. H., Quintanal-Villalonga, À., Martin, A., de Stanchina, E., Bhanot, U., Asher, M., Shah, N. S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108444 · Cited by 246
Wu, M., Xu, L.-G., Li, X., Zhai, Z., & Shu, H.-B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202285200 · Cited by 241
An ESCRT-III Polymerization Sequence Drives Membrane Deformation and Fission
Pfitzner, A.-K., Mercier, V., Jiang, X., Moser von Filseck, J., Baum, B., Šarić, A., & Roux, A. (2020) · Cell · doi:10.1016/j.cell.2020.07.021 · Cited by 214
Liu, H.-Y., Liu, Y.-Y., Yang, F., Zhang, L., Zhang, F.-L., Hu, X., Shao, Z.-M., & Li, D.-Q. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa130 · Cited by 212
West, H., McCleland, M. L., Cappuzzo, F., Reck, M., Mok, T. S. K., Jotte, R. M., Nishio, M., Kim, E., Morris, S., Zou, W., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003027 · Cited by 212
NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1
Zhang, Y., Jing, Y., Wang, Y., Tang, J., Zhu, X., Jin, W.-L., Wang, Y., Yuan, W., Li, X., & Li, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00489-4 · Cited by 199
Zheng, X., Wang, Q., Zhou, Y., Zhang, D., Geng, Y., Hu, W., Wu, C., Shi, Y., & Jiang, J. (2022) · Cancer Communications · doi:10.1002/cac2.12363 · Cited by 192
Self-citationPharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells
Drijvers, J. M., Gillis, J. E., Muijlwijk, T., Nguyen, T. H., Gaudiano, E. F., Harris, I. S., LaFleur, M. W., Ringel, A. E., Yao, C.-H., Kurmi, K., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0384 · Cited by 191
BRD4770 functions as a novel ferroptosis inhibitor to protect against aortic dissection
Chen, Y., Yi, X., Huo, B., He, Y., Guo, X., Zhang, Z., Zhong, X., Feng, X., Fang, Z., Zhu, X., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106122 · Cited by 164
CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis
Jiang, Y., Zhao, J., Li, R., Liu, Y., Zhou, L., Wang, C., Lv, C., Gao, L., & Cui, D. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02518-8 · Cited by 163
Kong, X., Chen, J., Xie, W., Brown, S. M., Cai, Y., Wu, K., Fan, D., Nie, Y., Yegnasubramanian, S., Tiedemann, R. L., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.003 · Cited by 161
NAT10‐mediated mRNA N4‐acetylcytidine modification promotes bladder cancer progression
Wang, G., Zhang, M., Zhang, Y., Xie, Y., Zou, J., Zhong, J., Zheng, Z., Zhou, X., Zheng, Y., Chen, B., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.738 · Cited by 160
Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation
Müller, F., Lim, J. K. M., Bebber, C. M., Seidel, E., Tishina, S., Dahlhaus, A., Stroh, J., Beck, J., Yapici, F. I., Nakayama, K., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01096-8 · Cited by 158
Cui, J., Wang, Y., Tian, X., Miao, Y., Ma, L., Zhang, C., Xu, X., Wang, J., Fang, W., & Zhang, X. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0237 · Cited by 143
Cheu, J. W., Lee, D. P. H., Li, Q., Goh, C. C., Bao, M. H., Yuen, V. W., Zhang, M. S., Yang, C., Chan, C. Y., Tse, A. P., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.001 · Cited by 138
Nguyen, H. P., Yi, D., Lin, F., Viscarra, J. A., Nakamura-Tabuchi, C., Ngo, K., Shin, G., Lee, A. Y.-F., Wang, Y., & Sul, H. S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.002 · Cited by 136
Targeting Ferroptosis as a Novel Approach to Alleviate Aortic Dissection
Li, N., Yi, X., He, Y., Huo, B., Chen, Y., Zhang, Z., Wang, Q., Li, Y., Zhong, X., Li, R., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72528 · Cited by 135
Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis
Hendricks, J. M., Doubravsky, C. E., Wehri, E., Li, Z., Roberts, M. A., Deol, K. K., Lange, M., Lasheras-Otero, I., Momper, J. D., Dixon, S. J., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.04.007 · Cited by 135
Involvement of FSP1-CoQ10-NADH and GSH-GPx-4 pathways in retinal pigment epithelium ferroptosis
Yang, M., Tsui, M. G., Tsang, J. K. W., Goit, R. K., Yao, K., So, K., Lam, W., & Lo, A. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04924-4 · Cited by 134
Ohiro, Y., Garkavtsev, I., Kobayashi, S., Sreekumar, K. R., Nantz, R., Higashikubo, B. T., Duffy, S., Higashikubo, R., Usheva, A., Gius, D. R., et al. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03049-1 · Cited by 128
Gao, G., Xie, Z., Li, E.-W., Yuan, Y., Fu, Y., Wang, P., Zhang, X., Qiao, Y., Xu, J., Hölscher, C., et al. (2021) · Journal of Natural Medicines · doi:10.1007/s11418-021-01491-4 · Cited by 128
NMT1 and NMT2 are lysine myristoyltransferases regulating the ARF6 GTPase cycle
Kosciuk, T., Price, I. R., Zhang, X., Zhu, C., Johnson, K. N., Zhang, S., Halaby, S. L., Komaniecki, G., Yang, M., DeHart, C. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14893-x · Cited by 125
Guo, J., Wang, R., & Fei, M. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.1a0422-211r · Cited by 119
Tan, J., Cao, R.-C., Zhou, L., Zhou, Z., Chen, H., Xu, J. M., Chen, X., Jin, Y.-C., Lin, J., Zeng, J.-L., et al. (2020) · Theranostics · doi:10.7150/thno.46934 · Cited by 111
ESCRT-III-mediated membrane repair in cell death and tumor resistance
Liu, J., Kang, R., & Tang, D. (2020) · Cancer Gene Therapy · doi:10.1038/s41417-020-0200-0 · Cited by 109
Borgese, N., Aggujaro, D., Carrera, P., Pietrini, G., & BASSETTI, M. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.135.6.1501 · Cited by 106
Yuan, J., Lv, T., Yang, J., Wu, Z., Yan, L., Yang, J., & Shi, Y. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102546 · Cited by 101
Zhang, Q., Li, N., Deng, L., Jiang, X., Zhang, Y., Lee, L. T. O., & Zhang, H. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01385-2 · Cited by 96
Targeting ferroptosis: Paving new roads for drug design and discovery
Gu, Y., Li, Y., Wang, J., Zhang, L., Zhang, J., & Wang, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.115015 · Cited by 89
Liu, Y., Cheng, D., Wang, Y., Xi, S., Wang, T., Sun, W., Li, G., Ma, D., Zhou, S., Li, Z., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05515-z · Cited by 89
Shao, C., Chen, Y., Yang, T., Zhao, H., & Li, D. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10327-x · Cited by 85
Pontel, L. B., Bueno-Costa, A., Morellato, A. E., Santos, J. C., Roué, G., & Esteller, M. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102408 · Cited by 85
Kim, S., Alsaidan, O., Goodwin, O., Li, Q., Sulejmani, E., Han, Z., Bai, A., Albers, T., Beharry, Z., Zheng, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0981 · Cited by 83
Yang, J., Jia, Z., Zhang, J., Pan, X., Wei, Y., Ma, S., Yang, N., Liu, Z., & Shen, Q. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102799 · Cited by 80
Jin, D., Chen, X., Liu, Y., Williams, C. M., Pedersen, L. C., Stafford, D. W., & Tie, J. (2023) · Nature Communications · doi:10.1038/s41467-023-36446-8 · Cited by 79
YOSHIOKA, H., Kawamura, T., Muroi, M., Kondoh, Y., Honda, K., Kawatani, M., Aono, H., Waldmann, H., Watanabe, N., & Osada, H. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00028 · Cited by 73
Bazhabayi, M., Qiu, X., Li, X., Yang, A., Wen, W., Zhang, X., Xiao, X., He, R., & Liu, P. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16963 · Cited by 72
TheCOQ2genotype predicts the severity of coenzyme Q10deficiency
Desbats, M. A., Morbidoni, V., Silic‐Benussi, M., Doimo, M., Ciminale, V., Cassina, M., Sacconi, S., Hirano, M., Basso, G., Pierrel, F., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw257 · Cited by 68
Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition
Wu, S., Chen, X., Jin, D., Stafford, D. W., Pedersen, L. G., & Tie, J. (2018) · Blood · doi:10.1182/blood-2018-01-830901 · Cited by 67
Song, L., Xiao, Z., Zhang, N., Yu, X., Cui, W., Xie, J., & Xu, H. (2021) · iScience · doi:10.1016/j.isci.2021.102431 · Cited by 64
Prognostic and Immunological Role of Key Genes of Ferroptosis in Pan-Cancer
Shi, Z., Tao, H., Fan, Z.-W., Song, S.-J., & Bai, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748925 · Cited by 64
Berkner, K. L., & Runge, K. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105759 · Cited by 64
Yue, M., Wei, J., Chen, W., Hong, D., Chen, T., & Fang, X. (2022) · Nutrients · doi:10.3390/nu14224886 · Cited by 62
AMID is a p53-inducible gene downregulated in tumors
Wu, M., Xu, L., Su, T., Tian, Y., Zhai, Z., & Shu, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207909 · Cited by 60
Song, Y., Tian, S., Zhang, P., Zhang, N., Shen, Y., & Deng, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.708699 · Cited by 59
Nuclear UHRF1 is a gate-keeper of cellular AMPK activity and function
Xu, X., Ding, G., Liu, C., Ding, Y., Chen, X. L., Huang, X., Zhang, C., Lu, S., Zhang, Y., Huang, Y., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00565-y · Cited by 52
Ma, P., Wang, W., Chen, J., Yuan, H., Lu, P., Gao, W., Ding, X., Lun, Y.-Q., Liang, R., He, Z., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3373828 · Cited by 45
He, X., Liang, S.-M., Wang, H., Tao, L., Sun, F., Wāng, Y., Zhang, C., Huang, Y., Xu, D., & Chen, X. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116452 · Cited by 44
Wang, F., Li, J., Zhao, Y., Guo, D. Y., Dongfan, L., Chang, S., Qiao, H., Li, J., Yang, Y., Zhang, C., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6041612 · Cited by 43
4‐Hydroxybenzoic acid restores CoQ 10 biosynthesis in human COQ 2 deficiency
Herebıan, D., Seibt, A., Smits, S. H. J., Rodenburg, R. J., Mayatepek, E., & Distelmaier, F. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.486 · Cited by 42
Overview of Ferroptosis and Synthetic Lethality Strategies
Kinowaki, Y., Taguchi, T., Onishi, I., Kirimura, S., Kitagawa, M., & Yamamoto, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179271 · Cited by 40
Yang, C. H., Shen, C., Feng, T., & Li, H. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ru0518-197rr · Cited by 36
Mei, J., Webb, S., Zhang, B., & Shu, H.-B. (2005) · Oncogene · doi:10.1038/sj.onc.1209121 · Cited by 35
Lv, Z., Wang, J., Wang, X., Mo, M., Tang, G., Xu, H., Wang, J., Li, Y., & Liu, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.666025 · Cited by 35
Wang, B., Zhang, X., Zhong, J., Wang, S., Zhang, C., Li, M., Hu, Q., Wang, S., Chen, L., Chen, W., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6160701 · Cited by 34
Gelbrich, N., Miebach, L., Berner, J., Freund, E., Saadati, F., Schmidt, A., Stope, M. B., Zimmermann, U., Burchardt, M., & Bekeschus, S. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.07.012 · Cited by 27
Gotorbe, C., Durivault, J., Meira, W., Cassim, S., Ždralević, M., Pouysségur, J., & Vučetić, M. (2022) · Antioxidants · doi:10.3390/antiox11122412 · Cited by 27
Miyauchi, W., Shishido, Y., Matsumi, Y., Matsunaga, T., Makinoya, M., Shimizu, S., Miyatani, K., Sakamoto, T., Umekita, Y., Hasegawa, T., et al. (2022) · Esophagus · doi:10.1007/s10388-022-00982-x · Cited by 27
Bu, C., Hu, S., Yu, J., Li, N., Gu, J., Sheng, Z., Yan, Z., & Bu, X. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-03032-1 · Cited by 21
AIFM2 is Required for High-Intensity Aerobic Exercise by Promoting Glucose Utilization
Nguyen, H. P., Villivalam, S. D., Jung, B. C., You, D., Lin, F., Yi, D., Pi, A., Ma, K., Jung, S., Park, S., et al. (2022) · Diabetes · doi:10.2337/db21-1114 · Cited by 11
Rishavy, M. A., Hallgren, K. W., Wilson, L. A., Hiznay, J. M., Runge, K. W., & Berkner, K. L. (2022) · Blood · doi:10.1182/blood.2021014275 · Cited by 10
Cited by
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
Metadata
- Authors
- Li, W., Liang, L., Liu, S., Yi, H., & Zhou, Y.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2023-09
- Volume
- 29
- Issue
- 9
- Pages
- 753-764
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W4381849204
- Cited by
- 287
- References
- 91
- FWCI
- 21.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.